Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Oct;18(4):389-397.
doi: 10.1007/s10689-019-00136-6.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history

Affiliations
Multicenter Study

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history

Mark A Jenkins et al. Fam Cancer. 2019 Oct.

Abstract

Before SNP-based risk can be incorporated in colorectal cancer (CRC) screening, the ability of these SNPs to estimate CRC risk for persons with and without a family history of CRC, and the screening implications need to be determined. We estimated the association with CRC of a 45 SNP-based risk using 1181 cases and 999 controls, and its correlation with CRC risk predicted from detailed family history. We estimated the predicted change in the distribution across predefined risk categories, and implications for recommended screening commencement age, from adding SNP-based risk to family history. The inter-quintile risk ratio for colorectal cancer risk of the SNP-based risk was 3.28 (95% CI 2.54-4.22). SNP-based and family history-based risks were not correlated (r = 0.02). For persons with no first-degree relatives with CRC, screening could commence 4 years earlier for women (5 years for men) in the highest quintile of SNP-based risk. For persons with two first-degree relatives with CRC, screening could commence 16 years earlier for men and women in the highest quintile, and 7 years earlier for the lowest quintile. This 45 SNP panel in conjunction with family history, can identify people who could benefit from earlier screening. Risk reclassification by 45 SNPs could inform targeted screening for CRC prevention, particularly in clinical genetics settings when mutations in high-risk genes cannot be identified. Yet to be determined is cost-effectiveness, resources requirements, community, patient and clinician acceptance, and feasibility with potentially ethical, legal and insurance implications.

Keywords: Colorectal cancer; Family history; Prediction model; Risk prediction; Single nucleotide polymorphism.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The distribution of lifetime risk of colorectal cancer (CRC) i.e., cumulative risk to age 80 years for the US population, by three categories of SNP-based risk and three categories of family history (. Risks are shown for those in the lowest quintile of SNP-based risk (left column), those at average risk (centre column), and those in the highest quintile of SNP-based risk (right column) by for those with no first-degree relative with CRC (top row), those with one first-degree relative with CRC (middle row), and those with two or more first-degree relatives with CRC (bottom row).
Figure 2.
Figure 2.
Cumulative risk of colorectal cancer (CRC) for the US population by three categories of SNP-based risk (lowest quintile, average, highest quintile) and two categories of family history (no first-degree relatives with CRC labelled “No family history” and two first-degree relatives with CRC).

Similar articles

Cited by

References

    1. Win AK, Ait Ouakrim D, Jenkins MA. Risk profiling: familial colorectal cancer. Cancer Forum 2014;38(1):15–25.
    1. Hopper JL. Disease-specific prospective family study cohorts enriched for familial risk. Epidemiol Perspect Innov 2011;8(1):2 doi 10.1186/1742-5573-8-2. - DOI - PMC - PubMed
    1. Dunlop MG, Tenesa A, Farrington SM, Ballereau S, Brewster DH, Koessler T, et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut 2013;62(6):871–81 doi 10.1136/gutjnl-2011-300537. - DOI - PMC - PubMed
    1. Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet 2019;51(1):76–87 doi 10.1038/s41588-018-0286-6. - DOI - PMC - PubMed
    1. Jenkins MA, Makalic E, Dowty JG, Schmidt DF, Dite GS, MacInnis RJ, et al. Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening. Future oncology 2016;12(4):503–13 doi 10.2217/fon.15.303. - DOI - PMC - PubMed

Publication types